John T. Treace Buys $1.37M of Treace Medical Concepts Inc (TMCI) — SEC Form 4, May 13, 2024

Open-Market Net Purchase · SEC Form 4

+$1,370,370

Equity position changed by +2.7%

Reporting Owner

John T. Treace

CEO 10% Owner

TXN 2024-05-13 · FILED 2024-05-13

Equity Position 11.4M sh 11,117,224 → 11,417,224

Equity Change +2.7% shares held after vs before

Filing Lag 0 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Treace Medical Concepts Inc

TMCI CIK 0001630627

Reporting Owner

Name	Relationship
John T. Treace CIK 0001856380	Director CEO 10% Owner

John T. Treace at Treace Medical Concepts Inc Full insider history

Bought (12 mo) $1,351,631

Sold (12 mo) —

More from this insider at Treace Medical Concepts Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1 F2	2024-05-10	P - Purchase	150,000 A	$4.58	+$686,880	5,943,095	Direct
Common StockF3 F2	2024-05-13	P - Purchase	150,000 A	$4.56	+$683,490	6,093,095	Direct

Non-Derivative Holdings

Title	Shares Held	Ownership
Common StockF4	1,605,000	Indirect By spouse
Common StockF4	1,471,250	Indirect By spouse as co-trustee of a trust
Common StockF5	1,839,063	Indirect as trustee of a trust
Common StockF5	408,816	Indirect as co-trustee of a trust

Footnotes (5)

F1: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.4700 to $4.7500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. Show more
F2: Includes 196,646 restricted stock units Show more
F3: The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3900 to $4.6400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. Show more
F4: The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee. Show more
F5: The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 4 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Treace Medical Concepts Inc

GET /v1/forms/4/0000950170-24-058878 API docs